Biotalys NV (FRA:86C) Other Stockholders Equity: €5.23 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:86C Biotalys NV FRA:86C
37 GF Score
Price €2.44
! 1 Warning Sign
View Full Analysis

What is Biotalys NV Other Stockholders Equity?

Biotalys NV FRA:86C +3.39% 37 Other Stockholders Equity is €5.23 Mil as of Dec. 2025. GuruFocus rates FRA:86C with a GF Score™ of 37/100. The stock has 1 warning sign investors should review.

Biotalys NV's Other Stockholders Equity for the quarter that ended in Dec. 2025 was €5.23 Mil.

Biotalys NV's quarterly Other Stockholders Equity increased from Dec. 2024 (€4.58 Mil) to Jun. 2025 (€4.92 Mil) and increased from Jun. 2025 (€4.92 Mil) to Dec. 2025 (€5.23 Mil).

Biotalys NV's annual Other Stockholders Equity increased from Dec. 2023 (€4.08 Mil) to Dec. 2024 (€4.58 Mil) and increased from Dec. 2024 (€4.58 Mil) to Dec. 2025 (€5.23 Mil).

Biotalys NV Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Biotalys NV's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotalys NV Other Stockholders Equity Chart

Biotalys NV Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 1.50 3.06 4.08 4.58 5.23

Biotalys NV Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.08 4.34 4.58 4.92 5.23
FRA:86C
37GF Score
Biotalys NV FRA:86C
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biotalys NV Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €5.23 Mil mean?
Biotalys NV (FRA:86C) has a Other Stockholders Equity of €5.23 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Biotalys NV and its competitors.
Is Biotalys NV's Other Stockholders Equity too high?
Biotalys NV's current Other Stockholders Equity is €5.23 Mil. Overall, Biotalys NV has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Biotalys NV's Other Stockholders Equity compare to CTVA and CF?
Biotalys NV's Other Stockholders Equity of €5.23 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for an Agriculture company?
A good Other Stockholders Equity depends on the Agriculture industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Biotalys NV and its competitors. Biotalys NV's current Other Stockholders Equity is €5.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotalys NV stock overvalued right now?
Biotalys NV (FRA:86C) has a current Other Stockholders Equity of €5.23 Mil. The current Other Stockholders Equity is €5.23 Mil. Biotalys NV's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Biotalys NV (FRA:86C), the current Other Stockholders Equity is €5.23 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotalys NV Business Description

Other Exchanges BTLS:Belgium
Address Buchtenstraat 11, Ghent, BEL, 9051
Biotalys NV is an Agricultural Technology (AgTech) company developing Precision Biocontrol solutions based on proteins for the protection of crops in both the pre and post harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Its pipeline EVOCA 1st Gen, EVOCA NG, BioFun-6, and BioFun-7. It operates in single segment.
37GF Score

Get the complete analysis for FRA:86C

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.44
Price